April 22, 2012

A lot has happened across GlaxoSmithKline’s consumer division in the past year. Drug Store News spoke with GSK Consumer chief marketing officer John Graham and chief customer officer Keith Loranger about the next move to be made out of the consumer division’s new playbook.

April 21, 2012

It was about a year ago that GlaxoSmithKline organized a dedicated sales team in support of community pharmacy. Drug Store News met with Jack Bailey, GSK SVP policy payers and vaccines, to discuss the progress of that team and the focus being discussed here at NACDS Annual.

June 2, 2015

Perrigo's new OTC product portfolio acquired out of the GSK/Novartis joint venture are sold primarily throughout Europe and Brazil. 

May 29, 2015

Flonase tells an impressive sales story in its first 16 weeks on the shelf.

May 11, 2015

GlaxoSmithKline pledges $20 million toward creation of Qura Therapeutics, a joint venture with the University of North Carolina at Chapel Hill dedicated to finding a cure for HIV.

May 7, 2015

Drug Store News on Sunday caught up with Brian McNamara, region head of Europe and the Americas of the recently christened GSK Consumer Healthcare, representing the joint venture between GlaxoSmithKline and Novartis to talk about what a consolidating OTC market means for the industry, and how GSK will be coming to market.

April 27, 2015

GlaxoSmithKline Consumer Healthcare on Monday announced that 2- and 4-mg Nicorette mini Lozenge is now available at most retail location in the United States following a shortage in supply.

March 4, 2015

Chattem’s launch of the first nasal corticosteroid onto OTC shelves represented the most significant success story in the cough-cold-allergy space in the past year. 

February 27, 2015

GlaxoSmithKline expects to complete its Novartis transaction in the week commencing March 2.

February 25, 2015

GlaxoSmithKline's Alli weight loss aid is making a return to shelves.

February 18, 2015

Flonase Allergy Relief partnered with The Weather Channel to provide allergy tools and resources. 

 

February 17, 2015

Lupin and Celon Pharma announced Tuesday that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler product which is a generic version of GlaxoSmithKline's Advair Diskus.

February 6, 2015

GlaxoSmithKline officially launched its Flonase allergy relief onto nonprescription shelves.

February 2, 2015

GlaxoSmithKline is gearing up for a Feb. 4 launch of its Flonase Allergy Relief (fluticasone propionate 50 mcg spray), an over-the-counter nasal spray indicated for relief of all nasal and eye-related allergy symptoms.

December 19, 2014

The overwhelming majority of GlaxoSmithKline shareholders on Thursday approved the proposed transaction with Novartis.

December 1, 2014

GlaxoSmithKline last week announced that the Federal Trade Commission has approved GSK's acquisition of Novartis' vaccines business and the creation of a joint consumer care company between GSK and Novartis.

 

October 30, 2014

The affiliated companies of Community Care of North Carolina, along with GlaxoSmithKline and the UNC Eshelman School of Pharmacy, on Thursday announced their intent to develop, implement and test new approaches to care delivery. 

October 23, 2014

GlaxoSmithKline expects to have its Ebola vaccine available by year's end.

October 15, 2014

GlaxoSmithKline launched Tums Chewy Delights, bringing to the iconic antacid brand a gummy delivery format. 

October 14, 2014

Following the completion of a joint venture between GlaxoSmithKline and Novartis' consumer health units, Brian McNamara, currently division head, Novartis OTC, will transition to GSK as Head of Americas and Europe for the consumer health businesses.

October 1, 2014

Bayer on Wednesday announced it has completed the acquisition of the consumer care business of the U.S. pharmaceuticals group Merck.

 

September 5, 2014

Mylan on Friday announced that it has launched a generic version of Hoffmann-La Roche's Boniva injection.

August 21, 2014

GlaxoSmithKline announced FDA approval for Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid medicine for the treatment of asthma in patients 12 years of age and older.

August 19, 2014

"The consumer healthcare market has experienced a steady stream of mergers and acquisitions in recent years. Some of this has created small ripples — like pebbles being gently tossed into still waters. Then there are the mega-mergers that have had a tsunami-like effect," writes Dave Wendland, Hamacher Resource Group VP, in his latest blog entry.